Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Early Phase 1)
Carcinoma, Hepatocellular (Phase 2)
Colorectal Neoplasms (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Diffuse Intrinsic Pontine Glioma (Phase 1/Phase 2)
Fallopian Tube Neoplasms (Phase 1/Phase 2)
Glioblastoma (Phase 2/Phase 3)
Glioma (Phase 1/Phase 2)
Hamartoma (Phase 1/Phase 2)
HLA-A2 Antigen (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Liver Neoplasms (Phase 2)
Melanoma (Phase 2)
Neoplasm Metastasis (Phase 2)
Ovarian Neoplasms (Phase 1/Phase 2)
Periodontal Diseases (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue